GlassScriptPhysician profile
Bret D Beavers
NPI 1821354119
$28,241.86
in general payments reported to CMS, 2019-2025
25 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,598 · 2020: $9,641 · 2021: $8,857 · 2022: $2,095 · 2023: $1,097 · 2024: $806 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684 · Consulting Fee: $750 · Travel and Lodging: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.68 |
| Consulting Fee | $750.00 |
| Travel and Lodging | $617.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Orthopaedic Solutions, INC. | $9,744.68 | 2019-2020 | |
| Pylant Medical | $5,267.12 | 2019-2025 | |
| Arthrex, INC. | $4,900.00 | 2021 | |
| Encore Medical, LP | $4,429.40 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $791.09 | 2021-2025 | Pangea, Blueprint Patient Specific Instrumentation, Mako |
| Tigon Medical LLC | $750.00 | 2023 | |
| Orthalign INC | $497.23 | 2021-2022 | |
| Smith+Nephew, INC. | $472.73 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Microraptor |
| Acumed LLC | $351.94 | 2019-2022 | |
| Globus Medical, INC. | $278.61 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $156.15 | 2020-2024 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2019 | |
| Ossur Americas, INC. | $112.20 | 2025 | |
| Depuy Synthes Sales INC. | $89.46 | 2019-2023 | Truespan Orthocord, Quickanchor Ethibond |
| Exsomed Corporation | $65.15 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $39.61 | 2019 | |
| Organogenesis INC. | $31.77 | 2023 | Puraply |
| Baxter Healthcare | $22.53 | 2022 | |
| Bioventus LLC | $22.27 | 2019 | |
| Fidia Pharma USA INC. | $19.32 | 2021 | |
| Pacira Therapeutics, INC. | $18.02 | 2021 | |
| Horizon Therapeutics Plc | $17.31 | 2022 | |
| Mimedx Group, INC. | $15.49 | 2024 | |
| Vericel Corporation | $13.13 | 2020 | |
| Linvatec Corporation | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Beavers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.